AbL Diagnostics SA Cash Flow Reinvestment Rate
AbL Diagnostics SA cash flow reinvestment rate. AbL Diagnostics SA (ABLD) has a Cash Flow Reinvestment Rate of 0.84x as of June 2025, reinvesting €400.39K (capex €400.39K ) from operating cash flow of €479.46K. Explore AbL Diagnostics SA (ABLD) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of AbL Diagnostics SA (2017–2025)
Cash flow reinvestment rate of AbL Diagnostics SA from 2017 to 2025. Historical reinvestment intensity for AbL Diagnostics SA across 5 annual periods. Explore AbL Diagnostics SA (ABLD) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
AbL Diagnostics SA Cash Flow Reinvestment Rate by Year (2017–2025)
AbL Diagnostics SA cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for AbL Diagnostics SA. For the full cash flow conversion analysis, see how efficiently does AbL Diagnostics SA generate cash.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | €792.67K | €1.51 Million | €792.67K | ▼ -48.1% |
| 2023 | 1.01x | €938.50K | €926.43K | €938.50K | — |
| 2020 | 0.00x | €0.00 | €29.51K | €0.00 | ▼ -100.0% |
| 2018 | 7.95x | €644.40K | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €305.02K | €675.20K | €305.02K | — |